Daiichi sankyo files declaratory judgement action related to its proprietary antibody drug conjugate technology

Daiichi sankyo files declaratory judgement action related to its proprietary antibody drug conjugate technology.daiichi sankyo co - filed declaratory judgement action in district court of delaware in response to receiving communications from seattle genetics.daiichi sankyo - filed declaratory judgement with respect to 2008-2015 collaboration with seattle genetics for development of antibody-drug conjugates.
SGEN Ratings Summary
SGEN Quant Ranking